Literature DB >> 15771233

Stereoselective taurine conjugation of (R)-benoxaprofen enantiomer in rats: in vivo and in vitro studies using rat hepatic mitochondria and microsomes.

Kiminori Mohri1, Kenji Okada, Leslie Z Benet.   

Abstract

PURPOSE: Identify (R)-BOP-T in rat bile after administration of (R)-BOT over a 12 h period.
METHODS: Each benoxaprofen (BOP) enantiomer was administered i.v. to bile duct-cannulated rats at a dose of 5 mg/kg. The optical isomers of BOP and its metabolites in plasma, urine, and bile were quantified using a chiral HPLC column. The amounts of BOP glucuronide (BOP-G), BOP taurine conjugate (BOP-T), and BOP enantiomers excreted into the bile over 12 h after administration of (R)-BOP were as follows: (R)-BOP-G and (S)-BOP-G, 2.1 +/- 0.5 and 6.2 +/- 1.4% of the dose; (R)-BOP-T and (S)-BOP-T, 5.6 +/- 1.8 and 0.7 +/- 0.3% of the dose; (R)-BOP and (S)-BOP, 0.7 +/- 0.1 and 1.7 +/- 0.2% of the dose, respectively, whereas after (S)-BOP administration, (S)-BOP-G and (S)-BOP were mainly excreted into the bile (14.3 +/- 1.8 and 3.0 +/- 0.4% of the dose, respectively). Only after (R)-BOP administration was the taurine conjugate of BOP found in the bile, and the configuration was R. BOP-T could not be found in the bile after (S)-BOP administration. To investigate the stereoselectivity of the conjugation enzymes responsible for BOP-T formation, in vitro studies were performed using rat hepatic organelles.
RESULTS: When (R)-BOP was used as a substrate, rat hepatic mitochondrial and microsomal fractions exhibited stereoselective BOP-T formation activity, with microsomal activity approximately 3.0 times greater than that of the mitochondria. That of (S)-BOP was approximately 2.1. Mean (R)/(S) ratios of BOP enantiomer for BOP-T formation in the mitochondrial and microsomal incubations were approximately 1.7 and 2.4, respectively.
CONCLUSION: Although in the in vivo studies, only (R)-BOP-T originated from (R)-BOP was found in the bile, the configuration of BOP-T formed by the incubations of (R)-BOP or (S)-BOP with rat hepatic mitochondria or microsomes was S for both.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771233     DOI: 10.1007/s11095-004-9012-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

Review 1.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

2.  Fatal cholestatic jaundice in elderly patients taking benoxaprofen.

Authors:  A Duthie; A Nicholls; M Freeth; P Moorhead; D Triger
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-03

3.  A radiochemical assay for glycine N-acyltransferase activity. Some properties of the enzyme in rat and rabbit.

Authors:  M O James; J R Bend
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

4.  Stereoselective metabolism of benoxaprofen in rats. Biliary excretion of benoxaprofen taurine conjugate and glucuronide.

Authors:  K Mohri; K Okada; L Z Benet
Journal:  Drug Metab Dispos       Date:  1998-04       Impact factor: 3.922

5.  Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers.

Authors:  M Furlanut; G Montanari; A Perosa; C Velussi; A Forgione; P Palatini
Journal:  Int J Clin Pharmacol Res       Date:  1985

6.  In vivo studies on chiral inversion and amino acid conjugation of 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid in rats and dogs.

Authors:  T Konishi; H Nishikawa; S Kitamura; K Tatsumi
Journal:  Drug Metab Dispos       Date:  1999-01       Impact factor: 3.922

7.  Stereospecific taurine conjugation of the trans-OH metabolite (active metabolite) of CS-670, a new 2-arylpropionic acid nonsteroidal anti-inflammatory drug, in dogs.

Authors:  M Asami; W Takasaki; H Iwabuchi; H Haruyama; K Wachi; A Terada; Y Tanaka
Journal:  Biol Pharm Bull       Date:  1995-11       Impact factor: 2.233

8.  Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans.

Authors:  R J Bopp; J F Nash; A S Ridolfo; E R Shepard
Journal:  Drug Metab Dispos       Date:  1979 Nov-Dec       Impact factor: 3.922

9.  Disposition and metabolism of benoxaprofen in laboratory animals and man.

Authors:  D H Chatfield; J N Green
Journal:  Xenobiotica       Date:  1978-03       Impact factor: 1.908

10.  Formation of glycine conjugate and (-)-(R)-enantiomer from (+)-(S)-2-phenylpropionic acid suggesting the formation of the CoA thioester intermediate of (+)-(S)-enantiomer in dogs.

Authors:  Y Tanaka; Y Shimomura; T Hirota; A Nozaki; M Ebata; W Takasaki; E Shigehara; R Hayashi; J Caldwell
Journal:  Chirality       Date:  1992       Impact factor: 2.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.